Search research articles
Contact Us
Filters
Showing results (461-470 of 517) with videos related to
Page
of 52
Sort By:
Oncotarget
|
August 29, 2015
Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells
Masaya Jimbo, Fernando F Blanco, Yu-Hung Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor
Michiel S van der Heijden, Jonathan R Brody, David A Dezentje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Cristina Maranto, Vindhya Udhane, David T Hoang, et al.
Nature Nanotechnology
|
November 7, 2009
Inhaled carbon nanotubes reach the subpleural tissue in mice
Jessica P Ryman-Rasmussen, Mark F Cesta, Arnold R Brody, et al.
Cancer Research Communications
|
August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic Cancer
Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Molecular Cancer Research : MCR
|
August 7, 2019
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition
Teena Dhir, Christopher W Schultz, Aditi Jain, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Pancreatic cancer-intrinsic HuR regulates the pro-tumorigenic properties of extracellular vesicles
Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Annals of Surgery
|
November 29, 2016
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial
Talar Tatarian, Wei Jiang, Benjamin E Leiby, et al.
Oncotarget
|
November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
Michael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
Cancer Biology & Therapy
|
November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress
Jennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 517) with videos related to
Sort By:
Page
of 52
Oncotarget
|
August 29, 2015
Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells
Masaya Jimbo, Fernando F Blanco, Yu-Hung Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor
Michiel S van der Heijden, Jonathan R Brody, David A Dezentje, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Cristina Maranto, Vindhya Udhane, David T Hoang, et al.
Nature Nanotechnology
|
November 7, 2009
Inhaled carbon nanotubes reach the subpleural tissue in mice
Jessica P Ryman-Rasmussen, Mark F Cesta, Arnold R Brody, et al.
Cancer Research Communications
|
August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic Cancer
Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Molecular Cancer Research : MCR
|
August 7, 2019
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition
Teena Dhir, Christopher W Schultz, Aditi Jain, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Pancreatic cancer-intrinsic HuR regulates the pro-tumorigenic properties of extracellular vesicles
Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Annals of Surgery
|
November 29, 2016
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial
Talar Tatarian, Wei Jiang, Benjamin E Leiby, et al.
Oncotarget
|
November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
Michael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
Cancer Biology & Therapy
|
November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress
Jennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Page
of 52